Therapeutic potential of the novel Bcl‐2/Bcl‐XL dual inhibitor, APG1252, alone or in combination against non‐small cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Carcinogenesis"
DOI: 10.1002/mc.23458
Abstract: Targeting the induction of apoptosis is a promising cancer therapeutic strategy with some clinical success. This study focused on evaluating the therapeutic efficacy of the novel Bcl‐2/Bcl‐XL dual inhibitor, APG1252‐M1 (also named APG‐1244; an in… read more here.
Keywords: cell; novel bcl; combination; inhibitor ... See more keywords